Rapid Novor: Selected Partner
Rapid Novor’s innovative next-generation protein sequencing technology enables researchers to confidently sequence and recombinantly express monoclonal antibodies from small protein samples of any species.
Key facts
- Specialization: Antibody discovery and sequencing services
- Technology: Next-generation protein sequencing using mass spectrometry and advanced bioinformatics
- Services: Diagnostics, therapies, reagents, and treatments development
- Website: rapidnovor.com
Location
Global Head Office and Lab
Unit 450, 137 Glasgow St.
Kitchener, Ontario, Canada N2G 4X8
Europe
Johan Enschedeweg 13
Uithoorn, Noord-Holland, 1422 DR, Netherlands
USA
135 Beaver Street, Suite 204
Waltham, MA 02452. USA
About Rapid Novor
Rapid Novor helps researchers decode immunity so they can rapidly and effortlessly develop diagnostics, therapies, reagents, and treatments. Through antibody discovery and antibody sequencing services Rapid Novor have empowered thousands of researchers.
The innovative next generation protein sequencing technology they have developed has the potential to unlock countless discoveries for human health. Their technology relies on mass spectrometry and advanced bioinformatics that delivers the correct sequence every time – this means you can confidently sequence and recombinantly express mAbs starting only with a small sample of protein from any species.
Our Workflow with Rapid Novor
Catalogue screening
- Off-the-shelf antibodies for rapid R&D screening & selection
- Catalogue of >25,000 constructs covering the human proteome
- Highly characterized and validated mono- and polyclonal preparations
Sequencing
- 100% accurate protein sequencing of any species and any isotype
- Sample requirement: 100 μg protein at >80% purity
- No quantity minimum/maximum
Recombinant expression
- High-quality transient expression at evitria
- Flexible scales to support both R&D and commercial manufacturing
- Recombinant format guarantees batch-to-batch consistency
Quality control & lot release testing
- Assay development and validation
- Technology transfer to in-house teams or batch release testing plans
- Functional assays
Unlock the full potential of your research with Rapid Novor and evitria
By partnering with Rapid Novor, we bring you unparalleled expertise in next-generation protein sequencing, enabling precise and confident recombinant antibody development from even the smallest protein samples. Combined with evitria’s transient antibody expression in CHO cells, our collaborative workflow ensures you receive consistent, high-quality results tailored to your specific needs.
Reach out to us to learn how we can support your research and accelerate your projects with our integrated solutions.
